FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Rene Belder

Research Profile

Chemicals & Drugs

Disorders

Concepts & Ideas

Multivariate Analysis

Co-author Network

Publications

TOP 3
David M Kendall; Cindy J Rubin; Pharis Mohideen; Jean-Marie Ledeine; Rene Belder; Jorge Gross; Paul Norwood; Michael O'Mahony; Kenneth Sall; Greg Sloan; Anthony Roberts; Fred T Fiedorek; Ralph DeFronzo
Improvement of glycemic control, triglycerides, and HDL cholesterol levels with muraglitazar, a dual (alpha/gamma) peroxisome proliferator-activated receptor activator, in patients with type 2 diabetes inadequately controlled with metformin monotherapy: A double-blind, randomized, pioglitazone-comparative study.
Greetje J de Grooth; Kim E Zerba; Shu-Pang Huang; Zenta Tsuchihashi; Todd G Kirchgessner; Rene Belder; Priya Vishnupad; Beihong Hu; Anke H E M Klerkx; Aeilko H Zwinderman; J Wouter Jukema; Frank M Sacks; John J P Kastelein; Jan Albert Kuivenhoven
The cholesteryl ester transfer protein (CETP) TaqIB polymorphism in the cholesterol and recurrent events study: no interaction with the response to pravastatin therapy and no effects on cardiovascular outcome: a prospective analysis of the CETP TaqIB polymorphism on cardiovascular outcome and interaction with cholesterol-lowering therapy.
Charles H Hennekens; Frank M Sacks; Andrew Tonkin; J Wouter Jukema; Robert P Byington; Bertram Pitt; Donald A Berry; Scott M Berry; Neville F Ford; Andy Walker; Kannan Natarajan; Chen Sheng-Lin; Frederick T Fiedorek; Rene Belder
Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Rene Belder (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2006: David M Kendall; Cindy J Rubin; Pharis Mohideen; Jean-Marie Ledeine; Rene Belder; Jorge Gross; Paul Norwood; Michael O'Mahony; Kenneth Sall; Greg Sloan; Anthony Roberts; Fred T Fiedorek; Ralph DeFronzo
Improvement of glycemic control, triglycerides, and HDL cholesterol levels with muraglitazar, a dual (alpha/gamma) peroxisome proliferator-activated receptor activator, in patients with type 2 diabetes inadequately controlled with metformin monotherapy: A double-blind, randomized, pioglitazone-comparative study.
Diabetes care 2006;29(5):1016-23.
2004: Greetje J de Grooth; Kim E Zerba; Shu-Pang Huang; Zenta Tsuchihashi; Todd G Kirchgessner; Rene Belder; Priya Vishnupad; Beihong Hu; Anke H E M Klerkx; Aeilko H Zwinderman; J Wouter Jukema; Frank M Sacks; John J P Kastelein; Jan Albert Kuivenhoven
The cholesteryl ester transfer protein (CETP) TaqIB polymorphism in the cholesterol and recurrent events study: no interaction with the response to pravastatin therapy and no effects on cardiovascular outcome: a prospective analysis of the CETP TaqIB polymorphism on cardiovascular outcome and interaction with cholesterol-lowering therapy.
Journal of the American College of Cardiology 2004;43(5):854-7.
2004: Charles H Hennekens; Frank M Sacks; Andrew Tonkin; J Wouter Jukema; Robert P Byington; Bertram Pitt; Donald A Berry; Scott M Berry; Neville F Ford; Andy Walker; Kannan Natarajan; Chen Sheng-Lin; Frederick T Fiedorek; Rene Belder
Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses.
Archives of internal medicine 2004;164(1):40-4.